Prostate Cancer - Results from #21200

Improving outcomes in high-risk prostate cancer with radiotherapy - Abstract February 15, 2014

Lymphotropic nanoparticle-enhanced MRI in prostate cancer: Value and therapeutic potential - Abstract February 15, 2014

Detection of recurrent prostate cancer after radical prostatectomy: Comparison of (11)C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil - Abstract February 15, 2014

Prostate cancer incidence in males with Lynch syndrome - Abstract February 15, 2014

Real-time in vivo rectal wall dosimetry using plastic scintillation detectors for patients with prostate cancer - Abstract February 14, 2014

Immunotherapy and therapeutic vaccines in prostate cancer: An update on current strategies and clinical implications - Abstract February 14, 2014

Bone targeted therapies for the prevention of skeletal morbidity in men with prostate cancer - Abstract February 14, 2014

Metastatic epidural spinal cord compression among elderly patients with advanced prostate cancer - Abstract February 13, 2014

Late rectal and bladder toxicity following radiation therapy for prostate cancer: Predictive factors and treatment results - Abstract February 13, 2014

Social support and adjustment among wives of men with prostate cancer - Abstract February 13, 2014

Positioning-related complications of minimally-invasive radical prostatectomies - Abstract February 13, 2014

Margin status of the vas deferens in radical prostatectomy specimens. Relevance or waste of time? - Abstract February 13, 2014

Role of multiparametric magnetic resonance imaging in the diagnosis of prostate cancer - Abstract February 13, 2014

Is intermittent androgen deprivation therapy beneficial for advanced prostate cancer patients? - Abstract February 13, 2014

Measuring health-related quality of life in men with prostate cancer: A systematic review of the most used questionnaires and their validity - Abstract February 13, 2014

Complex cellular composition of solitary fibrous tumor of the prostate - Abstract February 13, 2014

Phase 1/2 trial of orteronel (TAK-700) - an investigational 17,20-lyase inhibitor - in patients with metastatic castration-resistant prostate cancer - Abstract February 12, 2014

Predicting bone scan positivity after biochemical recurrence following radical prostatectomy in both hormone-naive men and patients receiving androgen-deprivation therapy: Results from the SEARCH database - Abstract February 12, 2014

Functional benefits are sustained after a program of supervised resistance exercise in cancer patients with bone metastases: Longitudinal results of a pilot study - Abstract February 12, 2014

Radiobiological comparison of two radiotherapy treatment techniques for high-risk prostate cancer - Abstract February 12, 2014

Page 1061 of 1434